Psoriasishttps://en.wikipedia.org/wiki/Psoriasis
Psoriasis mangrupikeun panyakit otoimun anu tahan panjang, henteu tepa anu dicirikeun ku daérah kulit anu teu normal. Wewengkon ieu beureum, atawa wungu dina sababaraha urang jeung kulit darker, garing, itchy, sarta scaly. Tatu kana kulit bisa memicu parobahan kulit psoriatic di titik éta, nu katelah "fenomena Koebner".

Rupa-rupa pangobatan tiasa ngabantosan ngontrol gejala. Pangobatan ieu kalebet krim stéroid, krim vitamin D3, sinar ultraviolét, sareng obat imunosupresif, sapertos methotrexate. Ngeunaan 75% tina involvement kulit ningkat kalawan creams nyalira. Rupa-rupa agén imunologis biologis dikembangkeun pikeun pengobatan psoriasis.

Psoriasis mangrupikeun gangguan umum sareng panyakit mangaruhan 2-4% tina populasi. Lalaki sareng awéwé kapangaruhan ku frékuénsi anu sami. Kasakit bisa dimimitian dina sagala umur, tapi ilaharna dimimitian dina dewasa. Psoriatic arthritis mangaruhan nepi ka 30% jalma kalawan psoriasis.

○ Perlakuan - Narkoba OTC
Cahya panonpoé bisa mantuan psoriasis sabab paparan panonpoé induces parobahan immunological di penderita psoriasis. Salep hydrocortisone hampang tiasa ngabantosan pikeun ngubaran sababaraha lesi leutik psoriasis.
#OTC steroid ointment

○ Perlakuan
Psoriasis mangrupikeun panyakit kronis sareng seueur agén pangobatan anu ditaliti. Biologis anu paling efektif tapi mahal pisan.
#High potency steroid ointment
#Calcipotriol cream
#Phototherapy
#Biologics (e.g. infliximab, adalimumab, secukinumab, ustekinumab)
☆ Dina hasil Stiftung Warentest 2022 ti Jerman, kapuasan konsumen sareng ModelDerm ngan ukur langkung handap tibatan konsultasi telemedicine anu mayar.
  • Deui jeung leungeun hiji jalma kalawan psoriasis
  • psoriasis has
  • Guttate Psoriasis; Ieu sering lumangsung sanggeus gejala tiis.
  • Guttate Psoriasis
  • Plak sisik kandel sareng erythema mangrupikeun manifestasi khas psoriasis.
  • Psoriasis dina palem. Upami éta lumangsung dina dampal leungeun, bisul tiasa ngabentuk.
  • Parah 'psoriasis pustular'.
  • Guttate Psoriasis
References Psoriasis 28846344 
NIH
 Phototherapy 33085287 
NIH
 Tumor Necrosis Factor Inhibitors 29494032 
NIH
Tumor necrosis factor (TNF)-alpha inhibitors, including etanercept (E), infliximab (I), adalimumab (A), certolizumab pegol (C), and golimumab (G), are biologic agents which are FDA-approved to treat ankylosing spondylitis (E, I, A, C, and G), Crohn disease (I, A and C), hidradenitis suppurativa (A), juvenile idiopathic arthritis (A), plaque psoriasis (E, I and A), polyarticular juvenile idiopathic arthritis (E), psoriatic arthritis (E, I, A, C, and G), rheumatoid arthritis (E, I, A, C, and G), ulcerative colitis (I, A and G), and uveitis (A).